Inflammatory bowel disease and the risk of fracture.

BACKGROUND & AIMS Although patients with inflammatory bowel disease (IBD) have reduced bone mass, there is controversy whether there is an increased risk of fracture. This study examines the risk of fracture and its predictors in patients with IBD. METHODS In a primary care- based nested case-control study, 231,778 fracture cases and 231,778 age- and sex-matched controls were recruited. A history of IBD was assessed from medical records. RESULTS The prevalence of IBD was 156 and 282 per 100,000 for Crohn's disease (CD) and ulcerative colitis (UC), respectively. Patients with IBD had an increased risk of vertebral fracture (odds ratio [OR], 1.72; 95% confidence interval [CI], 1.13-2.61) and hip fracture (OR, 1.59; 95% CI, 1.14-2.23). The risk of hip fracture was greater in patients with CD (OR, 1.86; 95% CI, 1.08-3.21) compared with UC (OR, 1.40; 95% CI, 0.92-2.13). Disease severity, assessed by the number of symptoms, predicted fracture even after adjusting for corticosteroid use (OR, 1.46; 95% CI, 1.04-2.04). Only 13% of patients with IBD who had already sustained a fracture were on any form of antifracture treatment. CONCLUSIONS Patients with IBD have a higher risk of fracture due to both disease activity and use of oral corticosteroids. However, few of these patients are receiving optimal bone-sparing therapy, highlighting the importance of increasing awareness of osteoporosis in those managing these patients.

[1]  M. Dougados,et al.  Low bone mineral density in patients with inflammatory bowel disease , 1992, Digestive Diseases and Sciences.

[2]  J. Mayberry,et al.  Osteoporosis and Determinants of Bone Density in Patients with Crohn's Disease , 1998, Digestive Diseases and Sciences.

[3]  D. Felsenberg,et al.  High prevalence of osteoporotic vertebral fractures in patients with Crohn’s disease , 2002, Gut.

[4]  C. Cooper,et al.  The Epidemiology of Corticosteroid-Induced Osteoporosis: a Meta-analysis , 2002, Osteoporosis International.

[5]  L. Melton,et al.  Long-term fracture risk in patients with Crohn's disease: a population-based study in Olmsted County, Minnesota. , 2002, Gastroenterology.

[6]  D. Felsenberg,et al.  Discordance between the degree of osteopenia and the prevalence of spontaneous vertebral fractures in Crohn's disease , 2002, Alimentary pharmacology & therapeutics.

[7]  Peter Vestergaard,et al.  Fracture risk in patients with celiac Disease, Crohn's disease, and ulcerative colitis: a nationwide follow-up study of 16,416 patients in Denmark. , 2002, American journal of epidemiology.

[8]  W. Bilker,et al.  Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease , 2002, Pharmacoepidemiology and drug safety.

[9]  F. Sylvester,et al.  Effect of Crohn's Disease on Bone Metabolism In Vitro: A Role for Interleukin‐6 , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  C. Cooper,et al.  Epidemiology of fractures in England and Wales. , 2001, Bone.

[11]  C. Cooper,et al.  Comparison of Calcaneal Ultrasound and DXA to Assess the Risk of Corticosteroid-Induced Osteoporosis: A Cross-sectional Study , 2001, Osteoporosis International.

[12]  E. Taioli,et al.  Bone Mineral Density and Body Composition in Ulcerative Colitis: A Six-Year Follow-up , 2001, Osteoporosis International.

[13]  P. J. Kelly,et al.  Inflammatory bowel disease: epidemiology and management in an English general practice population , 2000, Alimentary pharmacology & therapeutics.

[14]  C. Bernstein,et al.  The Incidence of Fracture among Patients with Inflammatory Bowel Disease: A Population-Based Cohort Study , 2000, Annals of Internal Medicine.

[15]  E. Schoon,et al.  Bone mineral density in patients with recently diagnosed inflammatory bowel disease. , 2000, Gastroenterology.

[16]  L Abenhaim,et al.  The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results , 2000, Pharmacoepidemiology and drug safety.

[17]  C. Cooper,et al.  Use of Oral Corticosteroids and Risk of Fractures , 2000 .

[18]  S. Manolagas.  Corticosteroids and Fractures: A Close Encounter of the Third Cell Kind , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  S. Laurberg,et al.  Fracture risk is increased in Crohn's disease, but not in ulcerative colitis , 2000, Gut.

[20]  G. Porro,et al.  Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn’s disease and ulcerative colitis , 2000, Journal of internal medicine.

[21]  E. Schoon,et al.  Osteopenia and osteoporosis in Crohn's disease: prevalence in a Dutch population-based cohort. , 2000, Scandinavian journal of gastroenterology. Supplement.

[22]  B. Wolffenbuttel,et al.  Osteoporosis as a risk in inflammatory bowel disease , 1999 .

[23]  A. Rieber,et al.  [Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors]. , 1999, Zeitschrift fur Gastroenterologie.

[24]  K. Mann,et al.  Reduced Bone Mineral Density and Unbalanced Bone Metabolism in Patients with Inflammatory Bowel Disease , 1998, Inflammatory bowel diseases.

[25]  R. Eliakim,et al.  Femoral neck osteopenia in patients with inflammatory bowel disease , 1998, American Journal of Gastroenterology.

[26]  Z. Tulassay,et al.  Altered Bone Metabolism in Inflammatory Bowel Disease , 1998, American Journal of Gastroenterology.

[27]  T. Walley,et al.  The UK General Practice Research Database , 1997, The Lancet.

[28]  J. Hyams,et al.  Alterations in bone metabolism in children with inflammatory bowel disease: an in vitro study. , 1997, Journal of pediatric gastroenterology and nutrition.

[29]  J. Jahnsen,et al.  Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study. , 1997, Gut.

[30]  I. Forgacs,et al.  Reduced bone density in patients with inflammatory bowel disease. , 1997, Gut.

[31]  T. Karttunen,et al.  A controlled study of bone mineral density in patients with inflammatory bowel disease. , 1995, Gut.

[32]  M. Dougados,et al.  Metabolic bone assessment in patients with inflammatory bowel disease. , 1995, Gastroenterology.

[33]  J. Sayre,et al.  Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[34]  W. Hannan,et al.  Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis. , 1994, Gastroenterology.

[35]  K. Rickels,et al.  [Osteopenia in chronic inflammatory bowel diseases. Results of a cross-sectional study using quantitative computerized tomography]. , 1994, Leber, Magen, Darm.

[36]  L. Abenhaim,et al.  The quality of information recorded on a UK database of primary care records: A study of hospitalizations due to hypoglycemia and other conditions , 1994 .

[37]  D. Clements,et al.  A four-year longitudinal study of bone loss in patients with inflammatory bowel disease. , 1993, Bone and mineral.

[38]  D. Clements,et al.  Longitudinal study of cortical bone loss in patients with inflammatory bowel disease. , 1992, Scandinavian journal of gastroenterology.

[39]  J. Compston,et al.  Osteoporosis in patients with inflammatory bowel disease. , 1987, Gut.